Mark D Willingham1, Elliott Karren, Amy M Shanks, Michael F O'Connor, Eric Jacobsohn, Sachin Kheterpal, Michael S Avidan. 1. From the Department of Anesthesiology, Washington University in Saint Louis School of Medicine, St. Louis, Missouri (M.D.W., M.S.A.); Department of Anesthesiology, University of Utah Medical School, Salt Lake City, Utah (E.K.); Center for Perioperative Outcomes Research, and Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan (A.M.S., S.K.); Department of Anesthesiology, University of Chicago, Chicago, Illinois (M.F.O.); and Department of Anesthesiology, University of Manitoba, Winnipeg, Manitoba, Canada (E.J.).
Abstract
BACKGROUND: An intraoperative concurrence of mean arterial pressure less than 75 mmHg, minimum alveolar concentration less than 0.8, and bispectral index less than 45 has been termed a "triple low" state. An association between triple low and postoperative mortality has been reported but was not replicated in a subsequent study. The authors pooled existing data from clinical trials to further evaluate the purported association in an observational study. METHODS: This retrospective observational study included 13,198 patients from three clinical trials: B-Unaware, BAG-RECALL, and Michigan Awareness Control Study. Patients with greater than 15 not necessarily consecutive minutes of triple low were propensity matched to controls with similar characteristics and comorbidities. A multivariable Cox proportional hazards model was used to evaluate the association between triple low duration and postoperative mortality. RESULTS:Thirty-day mortality was 0.8% overall, 1.9% in the triple low cohort, and 0.4% in the nontriple low cohort (odds ratio, 5.16; 95% CI, 4.21 to 6.34). After matching and adjusting for comorbidities, cumulative duration of triple low was significantly associated with an increased risk of mortality at 30 days (hazard ratio, 1.09; 95% CI, 1.07 to 1.11, per 15 min) and 90 days (hazard ratio, 1.09; 95% CI, 1.08 to 1.11, per 15 min). CONCLUSION: There is a weak independent association between the triple low state and postoperative mortality, and the propensity-matched analysis does not suggest that this is an epiphenomenon.
RCT Entities:
BACKGROUND: An intraoperative concurrence of mean arterial pressure less than 75 mmHg, minimum alveolar concentration less than 0.8, and bispectral index less than 45 has been termed a "triple low" state. An association between triple low and postoperative mortality has been reported but was not replicated in a subsequent study. The authors pooled existing data from clinical trials to further evaluate the purported association in an observational study. METHODS: This retrospective observational study included 13,198 patients from three clinical trials: B-Unaware, BAG-RECALL, and Michigan Awareness Control Study. Patients with greater than 15 not necessarily consecutive minutes of triple low were propensity matched to controls with similar characteristics and comorbidities. A multivariable Cox proportional hazards model was used to evaluate the association between triple low duration and postoperative mortality. RESULTS: Thirty-day mortality was 0.8% overall, 1.9% in the triple low cohort, and 0.4% in the nontriple low cohort (odds ratio, 5.16; 95% CI, 4.21 to 6.34). After matching and adjusting for comorbidities, cumulative duration of triple low was significantly associated with an increased risk of mortality at 30 days (hazard ratio, 1.09; 95% CI, 1.07 to 1.11, per 15 min) and 90 days (hazard ratio, 1.09; 95% CI, 1.08 to 1.11, per 15 min). CONCLUSION: There is a weak independent association between the triple low state and postoperative mortality, and the propensity-matched analysis does not suggest that this is an epiphenomenon.
Authors: Victor M Montori; Roman Jaeschke; Holger J Schünemann; Mohit Bhandari; Jan L Brozek; P J Devereaux; Gordon H Guyatt Journal: BMJ Date: 2004-11-06
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Rev Esp Salud Publica Date: 2008 May-Jun
Authors: Vinay Prasad; Andrae Vandross; Caitlin Toomey; Michael Cheung; Jason Rho; Steven Quinn; Satish Jacob Chacko; Durga Borkar; Victor Gall; Senthil Selvaraj; Nancy Ho; Adam Cifu Journal: Mayo Clin Proc Date: 2013-07-18 Impact factor: 7.616
Authors: Jilles B Bijker; Wilton A van Klei; Yvonne Vergouwe; Douglas J Eleveld; Leo van Wolfswinkel; Karel G M Moons; Cor J Kalkman Journal: Anesthesiology Date: 2009-12 Impact factor: 7.892
Authors: George A Mashour; Amy Shanks; Kevin K Tremper; Sachin Kheterpal; Christopher R Turner; Satya Krishna Ramachandran; Paul Picton; Christa Schueller; Michelle Morris; John C Vandervest; Nan Lin; Michael S Avidan Journal: Anesthesiology Date: 2012-10 Impact factor: 7.892
Authors: Miklos D Kertai; Ben J A Palanca; Nirvik Pal; Beth A Burnside; Lini Zhang; Furqaan Sadiq; Kevin J Finkel; Michael S Avidan Journal: Anesthesiology Date: 2011-03 Impact factor: 7.892
Authors: A Maheshwari; P J McCormick; D I Sessler; D L Reich; J You; E J Mascha; J G Castillo; M A Levin; A E Duncan Journal: Br J Anaesth Date: 2017-07-01 Impact factor: 9.166